Question: is this a 2) strong advice, 1) weak advice 0) no advice?

These data support MVC as a switch option for ritonavir-boosted PIs when partnered with a 2-N(t)RTI backbone, but not as part of N(t)RTI-sparing regimens comprising MVC with PI/r.
user
This is a weak advice
assistant